Financial Data and Key Metrics Changes - In the 4th Quarter, revenue was $9.7 million, a 3% increase from $9.5 million in the 3rd Quarter, but a 10% decline from $10.8 million in the 4th Quarter of the previous year [6] - Gross profit margin was 72.9% in the 4th Quarter, down from 74.2% in the same quarter last year, primarily due to inventory write-offs [7] - Net loss for the 4th Quarter was $588,000, or $0.05 per diluted share, compared to net income of $176,000, or $0.02 per diluted share in the 4th Quarter of 2024 [8] Business Line Data and Key Metrics Changes - Reorders as a percentage of total orders increased in the largest market compared to 2024, and sales of curated product bundles rose 10% for the Full Year [3] - Commissions expenses as a percentage of net sales for the 4th Quarter were 40.3%, down from 41.9% a year ago [7] - Selling general and administrative expenses were $3.8 million for the 4th Quarter, a slight decrease from $3.9 million a year ago [8] Market Data and Key Metrics Changes - Revenue in the primary market of Greater China increased by 2% compared to the 3rd Quarter, with notable growth in Taiwan and Peru during the 4th Quarter [6][3] - Japan and Colombia achieved strong increases throughout the year, contributing positively to overall performance [3] Company Strategy and Development Direction - The company is focusing on improving operational efficiency through restructuring initiatives, including relocating 40% of product sourcing to East Asia to reduce tariff uncertainty [4] - The company anticipates realizing approximately $1.5 million in annualized cost savings during 2026, which is expected to enhance profitability and performance [10] - Celebrating its 25th anniversary in 2026, the company plans special programs and events to leverage this milestone for renewed momentum [4] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to support goals in an evolving global environment, emphasizing a strong product portfolio and renewed focus on execution [5] - The management highlighted the importance of member engagement and ongoing demand for core products as key drivers for future growth [3] Other Important Information - Total cash, cash equivalents, and marketable securities were $28.9 million at the end of the year, down from $32 million at the end of the previous quarter [9] - The company paid out $9.2 million in dividends for the full year of 2025, reaffirming its commitment to returning capital to stockholders [9][10] Q&A Session Summary - No specific questions or answers were provided in the content, thus this section is not applicable.

Group 1 - The company has a strong portfolio and brand equity, which are key attractions for leadership positions [1] - The company operates in attractive markets and holds niche positions that are relied upon by physicians [1][2] - Customer interactions reveal appreciation for the company's products and portfolio, confirming the strength and market attractiveness [2]